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Summary
Objectives: Treatment of mitral valve stenosis with catheter balloon commissuro-
tomy (CBC) yields acceptable immediate results even when one commissure shows
calciﬁcation. However, the long-term outcomes in such cases remain unclear.
Methods: We examined the immediate and long-term (mean: 11± 5 years) out-
comes of 57 patients who underwent 58 CBC procedures. Patients were classiﬁed
into group A (no commissural calciﬁcation, n = 44) or group B (unilateral commis-
sural calciﬁcation, n = 13). From the appearance of the mitral valve just after CBC,
commissurotomy was judged to be bilateral, incomplete, or excessive. End points
were death, recurrence of congestive heart failure necessitating hospitalization,
embolism, repeat CBC, or mitral valve replacement.
Results: There were signiﬁcant numbers of unfavorable mitral valve morphologies
evaluated according to Sellors classiﬁcation, estimated by echocardiograms; Sellors
class I: 20 patients in group A vs. none in group B (p < 0.05). Class II: 24 in group
A vs. 10 in group B. and class III: none in group A vs. 3 in group B (p < 0.05). CBC
increased the mitral valve area (Gorin formula) from 1.3± 0.3 to 2.1± 0.5 cm2 in
patients in group A and from 1.1± 0.2 to 1.8± 0.4 cm2 in those in group B (p = n.s.).
Among the latter, there were signiﬁcantly more excessive commissurotomies than
in group A and no bilateral commissurotomy. The overall or event-free survival rate
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Introduction
Mitral valve (MV) catheter balloon commissuro-
tomy (CBC) is currently the procedure of choice
in patients with a suitable valve anatomy [1,2].
Patient selection is fundamental in predicting
the immediate and long-term outcomes of CBC
[2,3], and the evaluation and selection of can-
didates requires the precise assessment of MV
morphology [2—8]. The Massachusetts General Hos-
pital echocardiographic score (MGH echo score) is
presently the most widely used method for evalu-
ating the morphological characteristics of the MV,
and is associated with a high likelihood of a good
immediate and follow-up outcome following CBC
[3,5,9—16].
Unilateral or bilateral commissure calciﬁcation
was not scored by this world wide echo score,
but this extent of calciﬁcation can be classiﬁed
according to the University of Southern California
echocardiographic score (USC echo score); homoge-
neous density of the MV oriﬁce: grade 0, increased
density of the anterior or posterior commissure:
grade 1, and increased density of both commis-
sures: grade 2. This classiﬁcation of the extent
calciﬁcation is also a predictive factor of immedi-
ate results [8,14]. CBC yields acceptable immediate
results in patients with unilateral commissural cal-
ciﬁcation in special situations [2,17,18]. On the
other hand, long-term follow-up studies of CBC
recipients with unilateral commissural calciﬁcation
are scarce. The purpose of the present study was
to analyze long-term clinical outcomes following
CBC, comparing patients with unilateral commis-
sural calciﬁcation to those with no calciﬁcation.
Materials and methodsPatients and procedures
Our study population included 57 patients (44
women and 13 men with an average age of 56± 11
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p B showed a lower tendency than in group A (overall:
4.6%, p, n.s. event-free: 56.8% vs. 46.2%, respectively,
rs of all events in group B included post-CBC pulmonary
ttern of commissurotomy after CBC (p < 0.05). Excessive
linical events some years later, after the procedure.
olving a small number of subjects, long-term outcomes of
issural calciﬁcation receiving CBC showed no signiﬁcant
ose with commissural calciﬁcation absence. However, it
ul follow-up of CBC patients with unilateral commissural
Cardiology. Published by Elsevier Ireland Ltd. All rights
ears: mean± S.D. age) who underwent 58 consec-
tive CBCs between November 1987 and December
991 in Gifu Prefectual Hospital, whose early results
ere previously reported [19]. For the purpose of
nalysis, the patients were divided into two groups
ccording to their extent of commissural calciﬁca-
ion determined according to their USC echo score.
roup A included 44 patients (homogeneous density
f the MV oriﬁce: grade 1), while group B included
3 patients (increased density of the unilateral
ommissure: grade 1). Only 1 patient, assumed as
rade 2 (increased density of both commissures),
as ultimately excluded from this study, because
rade 2 case may obtain symptomatic beneﬁt with
BC before mitral valve replacement is undergone,
ven if the risk of CBC with both commissural cal-
iums is high, the long-term results may be less
avorable [17,18,20]. Written informed consent was
btained from all patients.
Contraindications for CBC were the presence of
left atrial thrombus on transoesophageal echocar-
iography, a mitral regurgitation grade of more
han 2/4, or the need for cardiac surgery due to
evere aortic, tricuspid, or coronary disease. Ref-
rence measurements of the MV area were made
sing planimetry from two-dimensional echocar-
iography. If planimetry was not feasible, Doppler
ressure half-time was used instead. The mean
itral gradient was assessed using the Doppler
ethod, and mitral regurgitation was quantiﬁed
sing color Doppler ﬂow imaging.
After the CBC procedure, we used echocardiog-
aphy to evaluate the appearance of the MV with
espect to whether it showed bilateral commis-
ural splitting without leaﬂets or chordal tearing or
upture. Incomplete commissurotomy was deﬁned
s showing only unilateral commissural splitting or
tretching of the leaﬂets and subvalvular stenosis
ithout tearing or rupture. Excessive commis-
urotomy was deﬁned as showing leaﬂets and/or
hordal tearing or rupture, with or without com-
issural splitting (Fig. 1).
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CBC was performed using the Inoue or double-
alloon technique, as previously described
4,19,21,22]. Left and right heart pressure
easurements, cardiac output, and diagnostic
xygen saturation runs were carried out before and
fter CBC. The MV area was calculated using the
orlin formula. Left ventriculography was carried
ut before and after CBC to assess the severity of
itral regurgitation using the Sellers classiﬁcation.
Patients were followed up for an average of
1± 5 years after CBC, and all clinical events were
ecorded. A clinical event was deﬁned as: (1) death
rom any cause, (2) MV replacement or repeat CBC,
r (3) the recurrence of congestive heart failure
hat necessitated hospitalization. Death occurring
uring the procedure and urgent MV replacement
mmediately following the procedure were included
n the follow-up clinical events. Clinical evaluations
ere carried out either through the patient’s visits
o the clinic or through telephone interviews with
he patient. When necessary, local physicians were
ontacted for additional information.tatistical analysis
ontinuous variables are expressed as
eans± S.D., while categorical variables are
T
1
e
epearance of the MV after the CBC procedure.
xpressed as a percentage. Student’s t-tests and
hi-squared tests were used to compare continuous
nd categorical variables, respectively. Values of
< 0.05 were considered signiﬁcant. Kaplan—Meier
stimates were used to assess total and event-free
urvival; groups were compared using the log-rank
est. The variables included in the univariate
nalysis were age, sex, pre-CBC NYHA functional
lass, history of previous surgical commissurotomy,
uoroscopic presence, post-CBC MV area based
n the Gorin formula and planetary echo, mitral
egurgitation, pulmonary artery pressure, and
he appearance of the MV. All analyses were
arried out using SAS software Version 5.0 (SAS
nstitute).
esults
atient population and pre-procedural
linical and morphological variables
he patient characteristics are summarized in
able 1 . All of the patients were symptomatic:
5 (26%) were in NYHA functional class III; 40
xhibited atrial ﬁbrillation; 14 had a history of
mbolism; 19 had a history of congestive heart
36 S. Tanaka et al.
Table 1 Baseline characteristics
Total Group A Group B p-Value
n 57 44 13
Age 56± 11 55± 11 60± 7
Female 44 77.2% 32 72.7% 12 92.3%
Atrial ﬁbrillation 40 70.2% 29 65.9% 11 84.6%
Previous OMC/CBC 7 12.3% 6 13.6% 1 7.7%
Previous heart failure 19 33.3% 11 25.0% 8 61.5% <0.05
Previous embolism 14 24.6% 10 22.7% 4 30.8%
NYHA
II 42 73.7% 33 75.0% 9 69.2%
III 15 26.3% 11 25.0% 4 30.8%
IV 0 0.0% 0 0.0% 0 0.0%
Sellors classiﬁcation
Class I 20 35.1% 20 45.5% 0 0.0% <0.01
Class II 34 59.6% 24 54.5% 10 76.9%
Class III 3 5.3% 0 0.0% 3 23.1% <0.01
Mitral regurgitation
Grade I 8 14.0% 6 13.6% 2 15.4%
Grade II 3 5.3% 2 4.5% 1 7.7%
9
diffe
v
c
m
ﬁFluoro calc 16 28.1%
Shown are means± S.D. p-Values are given only for signiﬁcant
failure necessitating hospitalization; and 8 (14%)
had undergone open mitral commissurotomy or CBC
previously. Patients in group B were older and pre-
sented more frequently with atrial ﬁbrillation than
group A. They also had a less favorable mitral mor-
phology, based on their Sellors classiﬁcation [23],
estimated from echocardiography; none with class
I, mobile cusps (pliable, non-calciﬁed) without sub-
w
c
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Table 2 Hemodynamic results
Total Group A
n 57 44
Left atrium pressure (mmHg)
Pre 15.8± 5.4 15.5± 5.
Post 10.5± 5.4 10.2± 4.
Cardiac index (l/min/m2)
Pre 3.1± 0.7 3.2± 0.
Post 3.3± 1.0 3.4± 1.
Mean mitral gradient (mmHg)
Pre 10.5± 4.7 10.5± 4.
Post 5.5± 2.9 5.4± 3.
MVA (Gorlin) cm2
Pre 1.3± 0.3 1.3± 0.
Post 2.0± 0.5 2.1± 0.
MVA (2 DE) cm2
Pre 1.19± 0.31 1.25± 0
Post 1.78± 0.39 1.84± 0
Shown are means± S.D. p-Values are given only for signiﬁcant diffe20.5% 7 53.8% <0.05
rences. OMC indicate open mitral commissurotomy.
alvular change, 10 (76.9%) with class II, thickened
usps (semipliable with local calciﬁcation) with
ild to moderate subvalvular changes (shortening,
brosis or fusion of the chordae), and 3 (23.1%)
ith class III, rigid cusps with severe subvalvular
hanges (the cusps, chordae and papillary mus-
les are fused into a rigid, ﬁbrous, funnel-shaped
tructure). They showed more valvular calciﬁca-
Group B p-Value
13
1 15.3± 6.6
8 11.3± 7.0
7 2.9± 0.51
0 3.0± 0.7
8 10.6± 4.4
0 5.8± 3.0
3 1.1± 0.2 <0.05
5 1.8± 0.4
.33 1.02± 0.22 <0.05
.39 1.52± 0.26 <0.05
rences.
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Table 3 Immediate and in-hospital outcomes
Total Group A Group B p-Value
n 57 44 13
Bilateral commissurotomy 36 63.2% 36 81.8% 0 0.0% <0.01
Incomplete commissurotomy (only
unilateral commissurotomy or only
stretch valve)
13 22.8% 6 13.6% 7 53.8% <0.05
Excessive commissurotomy with tear
in valve leaﬂets
8 14.0% 2 4.5% 6 46.2% <0.01
Death 0 0.0% 0 0.0% 0 0.0%
Tamponade 1 1.8% 0 0.0% 1 7.7%
MR> II 3 5.3% 1 2.3% 2 15.4%
1.8%
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p-Values are given only for signiﬁcant difference. MR > II indica
following the procedure.
ion under ﬂuoroscopy: 9 (20.5%) in group A and
(53.8%) in group B (p < 0.05).
mmediate results
ifty-six CBC procedures were performed using the
noue technique and one with the double-balloon
echnique. Table 2 shows the hemodynamic ﬁndings
efore and after CBC in the total patient population
nd among patients in groups A and B. Following
BC, the MV area as assessed by echocardiography
as increased from 1.25± 0.33 to 1.84± 0.39 cm2
n group A and from 1.02± 0.22 to 1.52± 0.26m2
n group B (p < 0.05).
Post-CBC echocardiography revealed that, after
he procedure, the degree of mitral regurgitation
as unchanged or aggravated by 1 grade, based
n Sellers classiﬁcation, in 55 cases and aggra-
ated by 2 or more grades in 3 cases. Severe mitral
egurgitation developed immediately after valvulo-
lasty, one patient in group B required urgent MV
eplacement. In addition, another group B patient
eveloped cardiac tamponade due to perforation
f the atrium during transseptal catheterization
Table 3).
Table 3 also summarizes the echocardiographic
ppearance of the MV following CBC. Thirty-six
g
t
f
p
Table 4 Clinical events and outcomes
Total
n 57
Out of hospital events 31 54.4%
Death from any cause 8 14.0%
Mitral valve replacement 15 25.9%
CHF recurrence 6 10.3%
Embolism 2 3.4%
CHF recurrence indicates recurrences of congestive heart failure
grade-related differences between any of the variables tested.0 0.0% 1 7.7%
at mitral regurgitation was aggravated by more than 2 grades
atients, all of whom were in group A, showed
ilateral commissural splitting. Eight in group A
xhibited unilateral splitting, while 4 showed tear-
ng of the valve leaﬂets. None of the group B
atients showed bilateral commissural splitting, 7
howed incomplete commissurotomy, and 6 showed
earing of the valve leaﬂets.
ong-term clinical events
he frequencies of clinical events during follow-up
re shown in Table 4. For the entire population,
linical follow-up data for a period averaging 11
ears were available for all 57 patients in whom
BC was attempted. Among them, there were 4
eaths from cardiac causes, 1 from cerebral infarc-
ion, 1 from pneumonia, and 2 from lung cancer.
ifteen patients had a recurrence of symptoms that
ecessitated MV replacement; 7 had a recurrence
f congestive heart failure that necessitated hospi-
alization; and 2 experienced cerebral infarctions.
linical events occurred less frequently in patients
n group A than group B. In all, 19 (43%) patients of
roup A experienced one or more clinical events,
otaling 21 events, including 6 (13.6%) deaths (3
rom cardiac death, 2 from lung cancer, and 1 from
neumonia), while 25 patients (57%) did not experi-
Group A Group B
44 13
25 56.8% 6 46.2%
6 13.6% 2 15.4%
10 22.7% 5 38.5%
4 9.1% 2 15.4%
1 16.7% 1 7.7%
that necessitated hospitalization. There were no signiﬁcant
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Figure 2 (A) Actuarial curves showing the probability
of survival. The bold line indicates survival among the
total patient population. The thin lines indicate survival
among group A and B patients. (B) Actuarial curves show-
ing the probability of event-free survival: the bold line
also indicates survival among the total patient popula-
Table 5 Summary of univariate analysis of factors
affecting event-free survival
Total Group A Group B
Age 0.83 0.64 0.93
Female 0.99 0.97 0.46
Atrial ﬁbrillation 0.62 0.38 0.78
Previous OMC/CBC 0.39 0.67 0.78
Previous heart failure 0.81 0.67 0.92
Previous embolism 0.84 0.92 0.54
Fluoro calc 0.91 0.22 0.12
NYHA 0.27 0.08 0.33
Left atrium pressure
after CBC
<0.01 0.06 0.02
Cardiac index after
CBC
0.02 <0.01 0.94
MVA (Gorlin)
Pre 0.89 0.43 0.42
Post 0.99 0.59 0.4
Pattern of
comissurotomy
after CBC
<0.01 0.22 0.03
MVA (2DE)
Pre 0.4 0.77 0.35
Post 0.17 0.33 0.43
Mitral regurgitation 0.03 0.52 0.23
l
t
i
a
clinical events increasing substantially after 5 years
(Fig. 3).
Brieﬂy, the present ﬁndings demonstrated: (1)
there are no signiﬁcant differences in long-termtion, and the thin lines show survival among group A and
B patients. There were no signiﬁcant differences between
two groups in terms total and event-free survival.
ence a clinical event. Seven (54%) patients in group
B experienced one or more clinical events, total-
ing 10 events, including 2 (15.4%) deaths, while 6
patients (46%) did not experience a clinical event.
Fig. 2 shows the survival and event-free survival
curves for the total population and for groups A and
B patients separately. Both the survival and event-
free survival rates throughout the follow-up period
tended to be better among patients in group A, but
the differences were not signiﬁcant.
Predictors of long-term results
Predictors of long-term events are shown in Table 5.
The univariate analysis identiﬁed that the pattern
of commissurotomy and the post-CBC cardiac index,
mitral regurgitation, and pulmonary artery pressure
were signiﬁcant predictors of clinical events in the
F
e
M
t
t(post)
OMC indicates open mitral commissurotomy.
ong-term for group B. Event-free survival among
hose with excessive commissurotomy was signif-
cantly lower than among those with incomplete
nd bilateral commissurotomy, with the numbers ofigure 3 Actuarial curves showing the probability of
vent-free survival based on the immediate post-CBC
V appearance: survival was signiﬁcantly better among
hose showing bilateral or incomplete commissurotomy
han in those excessive commissurotomy (p < 0.01).
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utcomes between groups A and B, but the long-
erm outcomes in group B showed a less favorable
endency than those in group A; (2) predictors of
ong-term events from univariate correlations iden-
iﬁed pattern of commissurotomy, cardiac index,
itral regurgitation, and left atrium pressure
fter CBC were immediate post-CBC variables; (3)
xcessive commisurotomy, which CBC of unilateral
ommissural calciﬁcation sometimes leads to, is
nfavorable in the long-term.
iscussion
n our study, CBC was carried out successfully in 95%
f patients in whom it was attempted, and the over-
ll 10-year survival rate was 86%, with an event free
urvival rate of 54%. Palaciou et al. (879 patients
ith a successful procedure, mean age: 55 years)
escribed survival (82% vs. 57%) and event-free sur-
ival (38% vs. 22%) at the 12-year follow-up with
cho schore <8 and echo schore >8, respectively [3].
amasaki et al. reported a 86% survival and a 66%
vent-free survival rate at 10 years in 82 patients
mean age: 52± 11 years) [24]. Fawzy et al., on
he other hand, reported event-free survival rates
t 10 and 13 years of 80± 3 and 74± 3%, respec-
ively, in 493 patients in younger patients (mean
ge: 31± 11) [16]. Previous studies showed that
ge is an important factor [3,10,12,16,25,26], and,
ith respect to that, our study population was older
han in those previous reports, and the long-term
utcome seemed to be acceptable.
It is well established that mitral valve mor-
hology is a strong predictor of immediate and
ong-term results [2,13,17,18]. Also, the unilateral
ommissural calciﬁcation group had a smaller MV
rea after CBC, the best predictor of late outcomes
n many past studies [3,27,28], than the group with
o commissural calciﬁcation. It is not surprising to
dentify an unfavorable outcome tendency in group
. However, the reason for the absence of signiﬁ-
ant differences might not only be the small sample
ize, but also that the base-line cardiac function
as similar in the two groups, the MV area obtained
as >1.5 cm2 and the mean pulmonary wedge pres-
ure after CBC was maintained at <18mmHg, which
s consistent with independent predictors in other
ollow-up studies [9,25].
Forty-six percent of the unilateral commissural
alcium group showed excessive comissurotomy,
nd, among the patients showing valve leaﬂet tear-
ng, only 20% had not experienced a clinical event
y the 15-year follow-up, and only 50% were event-
ree after 5 years. Though the primary mechanism
y which CBC increases the MV area is splitting
w
t
w
p39
t the commissures, calciﬁcation of the commis-
ures should be distinguished from calciﬁcation and
ncreased thickness of the body of leaﬂets and else-
here within the MV apparatus, which may not only
xert an even greater inﬂuence on the immediate
esults of CBC [8,17], but also lead to a clinically
nfavorable outcomes in the long-term.
In our study population, there was no signiﬁcant
ifference in the incidence of clinical events
etween the bilateral and incomplete commis-
urotomy subgroup. The mechanism by which CBC
ncreases the MV area is not only splitting at the
ommissures, but also stretching of the valve
eaﬂets and reduced subvalvular stenosis [29].
sing the technique of smaller balloon inﬂation
nd ﬁnal MV areas is one of the methods to avoid
ccelerating of the tearing of valve leaﬂets [30].
his might be result in a good course of CBC in
nilateral commissure calciﬁcation. However, it is
ecessary to recognize the risks of patients from
his baseline information (a smaller MV area, and
xcessive comissurotomy), and treats patients
ore vigorously.
CBC is effective for symptomatic patients (NYHA
unctional classes II, III, or IV), with moderate
r severe mitral stenosis and a valve morphology
avorable for CBC in the absence of left atrial
hrombus or moderate to severe mitral regurgita-
ion [2]. Among patients with MGH echo scores of
—16 or USC echo scores of 3—4, the results of CBC
ill not be good [18]; patients with high echo scores
re more likely to be older, show greater MV calci-
cation under ﬂuoroscopy, be in atrial ﬁbrillation,
nd have a history of previous mitral commissuro-
omy [3,12,30]. But, over the past 15 years, can-
idates for CBC have become older, with the mean
ge increasing at a rate of 0.7 years/year. In addi-
ion, there has been a highly signiﬁcant reduction in
he proportion of patients with an ideal anatomy for
BC (pliable valves and mild subvalvular disease),
nd an increase in the proportion of patients with
xtensive subvalvular disease [31]. It would thus be
xpected that the numbers of patients with unilat-
ral commissural calciﬁcation would be increasing.
BC is reasonable for patients with moderate or
evere mitral stenosis who have a non-pliable cal-
iﬁed valve, are in NYHA functional class III and IV,
nd are either not candidates for surgery or are
t high risk for surgery [2]. However, such patients
fter CBC were need to be more carefully followed
p, even if CBC is immediately successful.
This study has several important limitations. Itas a retrospective, non-randomized study in which
he study population was small and the mean age
as rather high, as compared with those reported
reviously. Comparison with other studies also may
[[
[
[
[
[
[
[
[
[
[
[
[
[
[
[40
be limited by the difference in the methods used to
evaluate mitral anatomy. That is to say, the classi-
ﬁcation that we used from the beginning is based
on the selection of patients for the most appropri-
ate surgical procedure. In addition, we evaluated
outcomes in terms of clinical events, rather than
echocardiologic or catheterization data obtained at
follow-up. Finally, the number of univariate tests
performed in the present study leads to an increase
in type I errors that are inherent in the exploratory
approach to testing for multiple variables.
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